Amgen second quarter profit dips, sales rise 20%
By Deena Beasley (Reuters) - Amgen on Tuesday said its second-quarter profit slipped 1% as higher expenses offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. Amgen …